RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| RDNT | RadNet, Inc. | 2025-12-02 04:07:20 | 80.01 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RDNT | 0000790526 | RadNet, Inc. | US7504911022 | 529900RECG94V2IZJ970 | 133326724 | Nasdaq | 8071 | Services-Medical Laboratories | 1231 | DE | 1510 COTNER AVE | LOS ANGELES | CA | 90025 | UNITED STATES | US | 3104787808 | 1510 COTNER AVE, LOS ANGELES, CA, 90025 | 1510 COTNER AVE, LOS ANGELES, CA, 90025 | RadNet, Inc. | — | 1981 | — | 11,000 | http://radnet.com | 4,200,000,000 | 77,032,154 | 77,146,342 | RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas. | 2025-11-27 15:47:10 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 4,200,000,000 | 2,100,000,000 | 100 | 74,041,715 | 5,566,272 | 8.1289 |
| 2023 | 2,100,000,000 | 1,100,000,000 | 110 | 68,475,443 | 10,639,199 | 18.3954 |
| 2022 | 1,000,000,000 | -500,000,000 | -33.3333 | 57,836,244 | 1,652,567 | 2.9414 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Cornelis Wesdorp | Chief Executive Officer, President | 2024 | 153,341 | 0 | 4,160,469 | — | 13,595 | 4,327,405 |
| Stephen M. Forthuber | Chief Operating Officer, President | 2024 | 800,000 | 650,000 | 650,017 | — | 52,882 | 2,152,899 |
| Howard G. Berger, M.D. | Chief Executive Officer, President | 2024 | 3,000,000 | 4,000,000 | 2,000,004 | — | 76,433 | 9,076,437 |
| Mark D. Stolper | Chief Financial Officer, Executive Vice President | 2024 | 700,000 | 575,000 | 574,982 | — | 33,157 | 1,883,139 |
| Norman R. Hames | Chief Operating Officer, President | 2024 | 800,000 | 650,000 | 650,017 | — | 36,486 | 2,136,503 |
| Fiscal Year | Employee Count |
|---|---|
| 2018 | 76 |
| 2017 | 76 |
| 2016 | 67 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1,829,664,000 | 1,616,630,000 | 1,430,061,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | — | — | — |
| Operating Expenses | 1,725,043,000 | 1,517,933,000 | 1,383,698,000 |
| Operating Income | 104,621,000 | 98,697,000 | 46,363,000 |
| Net Income | 2,793,000 | 3,044,000 | 10,650,000 |
| Earnings Per Share Basic | 0.04 | 0.05 | 0.19 |
| Earnings Per Share Diluted | 0.04 | 0.05 | 0.17 |
| Weighted Average Shares Outstanding Basic | 73,037,237 | 63,580,059 | 56,293,336 |
| Weighted Average Shares Outstanding Diluted | 74,762,332 | 64,658,299 | 57,320,870 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 740,020,000 | 342,570,000 | 127,834,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 185,821,000 | 163,707,000 | 166,357,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 1,019,252,000 | 579,276,000 | 367,184,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 694,791,000 | 604,401,000 | 565,961,000 |
| Other Assets Non Current | 13,000,000 | 9,000,000 | 24,100,000 |
| Total Assets Non Current | 232,750,000 | 224,936,000 | 134,694,000 |
| Total Assets | 3,286,690,000 | 2,690,473,000 | 2,433,907,000 |
| Accounts Payable | 96,450,000 | 122,888,000 | 102,678,000 |
| Deferred Revenue | 3,288,000 | 4,647,000 | 4,021,000 |
| Short Term Debt | 24,692,000 | 17,974,000 | 12,400,000 |
| Other Liabilities Current | 153,252,000 | 124,059,000 | 181,574,000 |
| Total Liabilities Current | 479,712,000 | 437,452,000 | 466,723,000 |
| Long Term Debt | 1,016,266,000 | 830,042,000 | 851,744,000 |
| Other Liabilities Non Current | 3,785,000 | 6,721,000 | 23,015,000 |
| Total Liabilities Non Current | 70,241,000 | 70,834,000 | 37,952,000 |
| Total Liabilities | 2,153,280,000 | 1,877,114,000 | 1,942,455,000 |
| Common Stock | 7,000 | 7,000 | 6,000 |
| Retained Earnings | -76,785,000 | -79,578,000 | -82,622,000 |
| Accumulated Other Comprehensive Income | -9,061,000 | -12,484,000 | -20,677,000 |
| Total Shareholders Equity | 902,308,000 | 630,695,000 | 332,995,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 12,500,000 | 12,200,000 | 10,100,000 |
| Share Based Compensation Expense | 29,833,000 | 26,785,000 | 23,770,000 |
| Other Non Cash Income Expense | -8,006,000 | -2,187,000 | -2,529,000 |
| Change In Accounts Receivable | 21,767,000 | -2,650,000 | 30,078,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 37,117,000 | 15,086,000 | 49,778,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 233,023,000 | 220,863,000 | 146,417,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 188,070,000 | 176,600,000 | 119,451,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -233,070,000 | -201,470,000 | -246,949,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 218,385,000 | 245,832,000 | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 863,757,000 | — | — |
| Repayment Of Long Term Debt | 1,900,000 | 0 | 0 |
| Other Financing Activities | 667,000 | 142,000 | 294,000 |
| Cash From Financing Activities | 397,950,000 | 195,635,000 | 93,647,000 |
| Change In Cash | 397,450,000 | 214,736,000 | -6,772,000 |
| Cash At End Of Period | 740,020,000 | 342,570,000 | 127,834,000 |
| Income Taxes Paid | 4,170,000 | 1,587,000 | 587,000 |
| Interest Paid | 84,601,000 | 64,695,000 | 39,151,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.04 | 0.05 | 0.19 |
| Price To Earnings Ratio | 1,746 | 695.4 | 99.1053 |
| Earnings Growth Rate | -20 | -73.6842 | -59.5745 |
| Price Earnings To Growth Ratio | -87.3 | -9.4376 | -1.6636 |
| Book Value Per Share | 15.5182 | 12.7927 | 8.7302 |
| Price To Book Ratio | 4.5005 | 2.718 | 2.1569 |
| Ebitda | 99,312,000 | 81,314,000 | 72,178,000 |
| Enterprise Value | 5,401,858,632.08 | 2,716,124,651.43 | 1,796,313,516.88 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 1.1537 | 1.3446 | 2.5951 |
| Capital Expenditures | 102,890,000 | 50,640,000 | — |
| Free Cash Flow | 130,133,000 | 170,223,000 | — |
| Return On Equity | 0.0031 | 0.0048 | 0.032 |
| One Year Beta | 1.4708 | 1.1873 | 1.2944 |
| Three Year Beta | 1.3079 | 1.2615 | 1.3948 |
| Five Year Beta | 1.3853 | 1.3417 | 1.2617 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Levitt Lawrence L | Director | 2025-11-25 | 2,700 | D | 164,956 |
| Patel Mital | EVP of Fin Planning, CAO | 2025-11-19 | 15,080 | D | 180,138 |
| Berger Howard G | Director, President, CEO | 2025-11-19 | 103,969 | A | 322,420 |
| Berger Howard G | Director, President, CEO | 2025-11-19 | 25,992 | A | 348,412 |
| Berger Howard G | Director, President, CEO | 2025-11-19 | 103,969 | D | 0 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 5,802,478 | 76,138 | 76.21 |
| Penn Capital Management Company, LLC | 2025-09-30 | 21,610,688 | 282,888 | 76.3931 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 15,623 | 205 | 76.2098 |
| CAPTRUST FINANCIAL ADVISORS | 2025-09-30 | 230,968 | 3,031 | 76.2019 |
| Advisory Services Network, LLC | 2025-09-30 | 7,850 | 103 | 76.2136 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYSGX | 247 | 18,823.87 | 0.3952 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYWAX | 247 | 18,823.87 | 0.3952 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 93 | 7,087.53 | 0.1061 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 93 | 7,087.53 | 0.1061 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 93 | 7,087.53 | 0.1061 |